Mark Brantly
 


Newly Diagnosed Donate! Discussion Forum Home



SupportEducationAdvocacy












 


Mark Brantly, MD

 
Univeristy of Florida College of Medicine
 

Topics:

  • What is DNA & Tissue Bank
  • Importance of Clinical Trials
  • Research Update
  • Living with Alpha-1
  • Future Therapies for Alphas
  • Alpha-1 Alleles
  • New Therapies and Early Identification
  • Alpha-1 Lung Disease and Current Research

Traveling from: Gainesville, FL


Profile:

Dr. Brantly is Professor of Medicine, Molecular Genetics and Microbiology in the University of Florida’s Division of Pulmonary and Critical Care Medicine. He is also Associate Director of the University of Florida’s Clinical Resource Center. The Alpha-1 Foundation DNA and Tissue Bank is operated under the direction of Dr. Brantly at the University of Florida. He has been extremely active in researching Alpha-1 Antitrypsin Deficiency for over 20 years and has worked with the Alpha-1 Foundation to increase national awareness about the disease and its effects on deficient individuals.  Dr. Brantly has been influential in expanding the Florida screening program and has helped coordinate efforts with the Medical University of South Carolina to increase responses to the Alpha-1 Coded Testing Study, a confidential and free testing service encouraging people to screen themselves for early detection.  Dr. Brantly has been awarded several honors including the Parker Family Fellowship in Pulmonary Research, the Alpha One Research Professorship, the Alpha-1 National Association Award, and the Visiting Professor Award from the Universita degli Studi di Modena.

 

 Learning Objectives

  • Obtain an understanding of the lung problems caused by Alpha-1
  • Hear about possible treatments and how education and self-management can improve outcomes
  • Learn which new therapies may prove promising and which ones have been eliminated from consideration

 

 


 

For more information please contact us at: 1-800-521-3025